In 2023, the expanding use of diet drugs called GLP-1 receptor agonists, such as Ozempic, for weight loss gained attention. These drugs not only helped people lose weight but also reduced the risk of heart attacks and strokes. They shed light on obesity as a hormonal malfunction caused by a diet high in sugar and refined starch. This challenges the misconception that obesity is solely due to lack of willpower. The drugs work by mimicking the hormone GLP-1 and have provided evidence for the hormonal view of obesity.
